MENLO PARK, Calif., March 5 /PRNewswire/ -- Solazyme, a leading algal
biotechnology company, today announced that it has named Dr. Donald E.
Trimbur to the position of Senior Director, Biofuel Development.
Dr. Trimbur is a metabolic engineer and microbiologist with more than
twenty years in academic and industrial biotechnology research and
development. He is an inventor on numerous patents and patent applications
in the fields of industrial biotechnology and metabolic engineering. He was
most recently Head of the Protein Science research group of Genencor
International, Inc. (www.genencor.com ), where he spent thirteen years.
While at Genencor, Dr. Trimbur also held a number of other positions,
including Leader of Pathway Design in the Metabolic Pathway Group and Head
of Functional Genomics. During this period he led industrial biotechnology
projects in a number of business areas, including his work on the
ground-breaking metabolic engineering project for highly efficient
bioproduction of 1, 3- propanediol with Genencor's partner Dupont. Dr
Trimbur was a member of the first editorial board of the influential
journal Metabolic Engineering.
"I have known Don for years and was thrilled that he was interested in
joining us," said Dr. Tony Day, VP of Research and Development at Solazyme.
"We are lucky to have a metabolic engineer of his caliber and with his
extensive industrial background to help drive the direction of our biofuels
Dr. Trimbur received his Ph.D. in microbiology from Cornell University.
He then performed postdoctoral fellowships at both the University of
British Columbia, where he worked with Dr. Stephen Withers on enzyme
mechanisms of beta-glucosidases, and at Pennsylvania State University in
the lab of Dr. Jean Benchley, where he studied psychophilic enzymes.
More information on Solazyme and Dr. Trimbur can be found online at
Founded in 2003 in Menlo Park, California, Solazyme is devoted to
harnessing the energy-harvesting machinery of various species of algae to
produce valuable products. The Company utilizes proprietary genetic
engineering methods to develop and optimize commercially relevant
biochemical pathways for production of biofuels and health and wellness
materials. For more information, please visit our website:
http://www.solazyme.com or contact Jonathan Wolfson at 650-780-4777.
SOURCE Solazyme, Inc.